Cognitive impairment and depression outcomes in the IMPACT study.

INTRODUCTION It is unclear whether cognitive impairment affects acute and long-term treatment response in geriatric depression. In addition, little is known about the long-term outcome of depression among older individuals who experience cognitive decline during a course of treatment for depression. The authors examined both of these issues using data from the IMPACT trial. METHODS The sample consisted of 1,684 participants in the IMPACT study who had baseline and two-year follow-up data. Subjects were randomized to one year of active intervention with a depression care manager or usual care. After one year, all subjects had usual care for another year. Data were collected for two years. The authors used the Six-Item Cognitive Screener to examine acute and long-term effects on depression outcome of baseline cognitive impairment and of cognitive decline. Depression measures included the HSCL-20 and an estimation of depression-free days. Outcomes were determined using both linear regression and repeated-measures analyses. RESULTS Depressed subjects in the active intervention group had better depression outcomes at one year regardless of baseline cognitive impairment. Cognitively impaired subjects within each treatment group had similar outcomes to subjects without cognitive impairment. Subjects who experienced decline in cognitive score over two years had worse 24-month depression outcomes compared with subjects whose cognitive score did not change. CONCLUSIONS Cognitively impaired depressed patients can experience significant improvement in depression with appropriate acute and continuation-phase management. Older depressed adults experiencing ongoing cognitive decline may be at higher risk for poor depression outcomes and may require more careful clinical monitoring and management of both cognitive and affective symptoms.

[1]  B. Pollock,et al.  Changes in cognitive functioning following treatment of late-life depression. , 2000, The American journal of psychiatry.

[2]  J. Lave,et al.  Cost-effectiveness of treatments for major depression in primary care practice. , 1998, Archives of general psychiatry.

[3]  P. Sachdev,et al.  The Prevalence of ‘Cognitive Impairment no Dementia’ in Community-Dwelling Elderly: A Pilot Study , 2004 .

[4]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[5]  L. Covi,et al.  SCL-90: an outpatient psychiatric rating scale--preliminary report. , 1973, Psychopharmacology bulletin.

[6]  H. Sackeim,et al.  Sertraline treatment of elderly patients with depression and cognitive impairment , 2003, International journal of geriatric psychiatry.

[7]  Jürgen Unützer,et al.  Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary Care , 2002, Medical care.

[8]  M. Hegel,et al.  Role of behavioral health professionals in a collaborative stepped care treatment model for depression in primary care: Project IMPACT. , 2002 .

[9]  G. Alexopoulos,et al.  Executive dysfunction in geriatric depression. , 2002, The American journal of psychiatry.

[10]  Jürgen Unützer,et al.  Depression Treatment in a Sample of 1,801 Depressed Older Adults in Primary Care , 2003, Journal of the American Geriatrics Society.

[11]  M. Hegel,et al.  Improving Primary Care for Depression in Late Life: The Design of a Multicenter Randomized Trial , 2001, Medical care.

[12]  A. Stoudemire,et al.  Cognitive outcome following tricyclic and electroconvulsive treatment of major depression in the elderly. , 1991, The American journal of psychiatry.

[13]  Jürgen Unützer,et al.  A comparison of imputation methods in a longitudinal randomized clinical trial , 2005, Statistics in medicine.

[14]  B. Pollock,et al.  The nature and determinants of neuropsychological functioning in late-life depression. , 2004, Archives of general psychiatry.

[15]  B. Pollock,et al.  Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. , 2003, Journal of psychiatric research.

[16]  M. Trabucchi,et al.  Paroxetine and fluoxetine effects on mood and cognitive functions in depressed nondemented elderly patients. , 2002, The Journal of clinical psychiatry.

[17]  Christopher M Callahan,et al.  Six-Item Screener to Identify Cognitive Impairment Among Potential Subjects for Clinical Research , 2002, Medical care.

[18]  W. Katon,et al.  Can depression treatment in primary care reduce disability? A stepped care approach. , 2000, Archives of family medicine.

[19]  H. Wagner,et al.  Greater depression severity associated with less improvement in depression-associated cognitive deficits in older subjects. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[20]  Mark T Hegel,et al.  Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. , 2002, JAMA.

[21]  G. Alexopoulos,et al.  Executive dysfunction and long-term outcomes of geriatric depression. , 2000, Archives of general psychiatry.

[22]  A. Leuchter,et al.  Executive dysfunction predicts nonresponse to fluoxetine in major depression. , 2000, Journal of affective disorders.

[23]  D. Sheehan,et al.  The measurement of disability. , 1996 .

[24]  D. Rubin.  Multiple imputation for nonresponse in surveys , 1989 .

[25]  G. Alexopoulos,et al.  The course of geriatric depression with "reversible dementia": a controlled study. , 1993, The American journal of psychiatry.

[26]  P. Modrego,et al.  Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. , 2004, Archives of neurology.

[27]  M Davies,et al.  The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. , 1992 .